Improved survival in patients with diabetic nephropathy

E. R. Mathiesen*, K. Borch-Johnsen, D. V. Jensen, T. Deckert

*Corresponding author af dette arbejde

    Publikation: Bidrag til tidsskriftArtikelForskningpeer review


    The effect of early antihypertensive treatment on survival of patients with diabetic nephropathy was evaluated by studying two cohorts of Type 1 (insulin-dependent) diabetic patients developing persistent proteinuria in I: 1957-1973 (late treatment group n=49) and II: 1979-1983 (early treatment group n=71). At onset of nephropathy, the two cohorts were comparable with regard to age (29(8) vs 30(8) years, mean (SD)), duration of diabetes (16(6) vs 18(7) years), blood pressure (132(16)/85(11) vs 134(16)/86(8) mm Hg), proteinuria (0.8 (0.5-1.2) vs 0.8 (0.6-1.2) g × 24 h-1, median (quartiles)) and serum creatinine (87(14) vs 85(16) μmol×1-1). The patients were followed frequently at the outpatients' clinic until death or for a median duration of 8 years. In the first cohort antihypertensive treatment was seldom used, whereas, in the second cohort antihypertensive treatment was started when blood pressure reached 144(18)/93(7) mm Hg. The probability of survival with a functioning kidney for more than 8 years was 48% in the first cohort and 87% in the second cohort, p<0.001. The improvement of survival was due mainly to a decreased mortality from uraemia. Early antihypertensive treatment is the most likely explanation for this improvement.

    Sider (fra-til)884-886
    Antal sider3
    Udgave nummer12
    StatusUdgivet - 1 dec. 1989


    Udforsk hvilke forskningsemner 'Improved survival in patients with diabetic nephropathy' indeholder.